Session Details

P012 Sunscreens: What's Controversial, What's Misleading, and What's New

Sat, Jul 12, 9:00 AM - 11:00 AM
Grand Ballroom B
2 CME Available 2 Hour Parallel
View Map

DESCRIPTION

Sunscreens were developed to prevent sunburn. The sun protection factor (SPF) quantifies this UVB protection. Photoaging, melasma and other dyspigmentation affect both light and dark skin and appear substantially due to chronic UVA exposure, encouraging development of broad spectrum sunscreens that typically contain chemical and/or mineral filters. Chemical filters effectively block UVB but raise concerns regarding systemic absorption and environmental damage, while conventional mineral filters provide good UVB/UVA protection only if they remain visible on skin. New technology comprising smaller and more uniform zinc oxide particles employs MIe scattering to overcome the safety, efficacy and cosmetic issues now impeding photoprotection.

LEARNING OBJECTIVES

1.

Identify positive and negative characteristics of conventional chemical versus mineral sunscreens

2.

Define “broad spectrum” designation and understand the rationale for long wave UV protection

3.

Define “broad spectrum” designation and understand the rationale for long wave UV protection

SCHEDULE

2:00 PM

Introduction

Sandy Sharon Tsao, MD, FAAD

2:05 PM

Sunscreens – Misconceptions and Misinformation

Sandy Sharon Tsao, MD, FAAD

2:30 PM

Sunscreen and Skin Cancer

Hensin Tsao, MD, PhD, FAAD

3:05 PM

Sun Protection Needs for Darker Skin Phototypes

Sandy Sharon Tsao, MD, FAAD

3:25 PM

What’s New in Sunscreens and Photoprotection

Tasneem Mohammad, MD, FAAD

3:45 PM

Q and A Panel

SPEAKERS

Tasneem Mohammad, MD, FAAD

Tasneem Mohammad, MD, FAAD

Hensin Tsao, MD, PhD, FAAD

Hensin Tsao, MD, PhD, FAAD

Sandy Sharon Tsao, MD, FAAD

Sandy Sharon Tsao, MD, FAAD

SPEAKER DISCLOSURES

Tasneem Mohammad, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); atheneum – Consultant(Honoraria); Avita – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beiersdorf – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Speaker(Honoraria); Clinuvel – Investigator(Grants/Research Funding); Disc Medicine – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ferndale Laboratories, Inc. – Consultant (1099 relationship)(Honoraria); Guidepoint Global, LLC – Consultant(Honoraria); Immune Tolerance Network – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Kenvue – Consultant (1099 relationship)(Honoraria); Medscape – Speaker/Faculty Education(Honoraria); Mitsubishi Tanabe Pharma Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); polaris health – Speaker/Faculty Education(Honoraria); Third Bridge – Consultant (1099 relationship)(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);

Hensin Tsao, MD, PhD, FAAD

Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);

Sandy Sharon Tsao, MD, FAAD

Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);